Real-world experience with caplacizumab in the management of acute TTPTina Dutt, Marie Scully, Matthew Stubbs et al.|Blood|2020Cited by 157
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VIPhillip L.R. Nicolson, Steve P. Watson|Haematologica|2018Cited by 70
Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in miceChristopher W. Smith, Phillip L.R. Nicolson|Blood Advances|2024Cited by 14